Document is current
Any future updates will be listed below
-
Authors
Liccardo, Francesca
Śniegocka, Martyna
Tito, Claudia
Iaiza, Alessia
Ottone, Tiziana
Divona, Mariadomenica
Travaglini, Serena
Mattei, Maurizio
Cicconi, Rosella
Miglietta, Selenia
Familiari, Giuseppe
Nottola, Stefania Annarita
Petrozza, Vincenzo
Tamagnone, Luca
Voso, Maria Teresa
Masciarelli, Silvia
Fazi, Francesco http://orcid.org/0000-0003-2910-7912
-
Funding
Funding for this research was provided by:
Fondazione AIRC per la ricerca sul cancro ETS (IG 2018-ID 21406)
Istituto Pasteur-Fondazione Cenci Bolognetti
- License Information
-
More Information
Article History
Received: 16 May 2023
Accepted: 10 August 2023
First Online: 31 August 2023
Declarations
:
: AML BM samples were collected at diagnosis at the Department of Biomedicine and Prevention at the University of Rome Tor Vergata, after obtaining informed consent from all patients and approval of the study by the IRB of Policlinico Tor Vergata, Rome. The study on the murine model was approved by the Italian Ministry of Health.
: Not applicable.
: The authors declare that they have no competing interests.
